Logo image of NRZ

NEW RESIDENTIAL INVESTMENT (NRZ) Stock Fundamental Analysis

NYSE:NRZ - New York Stock Exchange, Inc. - US64828T2015 - REIT - Currency: USD

10.89  -0.02 (-0.18%)

After market: 10.9 +0.01 (+0.09%)

Fundamental Rating

2

Taking everything into account, NRZ scores 2 out of 10 in our fundamental rating. NRZ was compared to 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. NRZ has a bad profitability rating. Also its financial health evaluation is rather negative. NRZ is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NRZ was profitable.
NRZ Yearly Net Income VS EBIT VS OCF VS FCFNRZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 1B -1B 2B

1.2 Ratios

Industry RankSector Rank
ROA 3.03%
ROE 14.99%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NRZ Yearly ROA, ROE, ROICNRZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20

1.3 Margins

Industry RankSector Rank
OM 36.91%
PM (TTM) 21.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRZ Yearly Profit, Operating, Gross MarginsNRZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

NRZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NRZ has been increased compared to 1 year ago.
The debt/assets ratio for NRZ has been reduced compared to a year ago.
NRZ Yearly Shares OutstandingNRZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M
NRZ Yearly Total Debt VS Total AssetsNRZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 10B 20B 30B 40B

2.2 Solvency

NRZ has a Debt/Equity ratio of 1.41. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC3.42%
NRZ Yearly LT Debt VS Equity VS FCFNRZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B 8B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

5

3. Growth

3.1 Past

NRZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.75%, which is quite good.
Measured over the past years, NRZ shows a decrease in Earnings Per Share. The EPS has been decreasing by -6.98% on average per year.
Looking at the last year, NRZ shows a very strong growth in Revenue. The Revenue has grown by 33.30%.
The Revenue has been growing by 22.92% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)18.75%
EPS 3Y-14.33%
EPS 5Y-6.98%
EPS Q2Q%0%
Revenue 1Y (TTM)33.3%
Revenue growth 3Y16.4%
Revenue growth 5Y22.92%
Sales Q2Q%-20.18%

3.2 Future

Based on estimates for the next years, NRZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.37% on average per year.
Based on estimates for the next years, NRZ will show a decrease in Revenue. The Revenue will decrease by -1.61% on average per year.
EPS Next Y-0.27%
EPS Next 2Y4.29%
EPS Next 3Y7.05%
EPS Next 5Y8.37%
Revenue Next Year10.11%
Revenue Next 2Y14.85%
Revenue Next 3Y-0.51%
Revenue Next 5Y-1.61%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
NRZ Yearly Revenue VS EstimatesNRZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
NRZ Yearly EPS VS EstimatesNRZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

NRZ is valuated cheaply with a Price/Earnings ratio of 7.16.
Compared to an average S&P500 Price/Earnings ratio of 29.62, NRZ is valued rather cheaply.
The Price/Forward Earnings ratio is 6.72, which indicates a rather cheap valuation of NRZ.
NRZ is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 7.16
Fwd PE 6.72
NRZ Price Earnings VS Forward Price EarningsNRZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.37
NRZ Per share dataNRZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y4.29%
EPS Next 3Y7.05%

More info and screens

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.81%, NRZ is a good candidate for dividend investing.
NRZ's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 9.81%

5.2 History

The dividend of NRZ decreases each year by -24.82%.
NRZ has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-24.82%
Div Incr YearsN/A
Div Non Decr YearsN/A
NRZ Yearly Dividends per shareNRZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 0.5 1 1.5

5.3 Sustainability

23.27% of the earnings are spent on dividend by NRZ. This is a low number and sustainable payout ratio.
DP23.27%
EPS Next 2Y4.29%
EPS Next 3Y7.05%
NRZ Yearly Income VS Free CF VS DividendNRZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 0 1B -1B 2B
NRZ Dividend Payout.NRZ Dividend Payout, showing the Payout Ratio.NRZ Dividend Payout.PayoutRetained Earnings

More info and screens

NEW RESIDENTIAL INVESTMENT

NYSE:NRZ (8/1/2022, 8:22:09 PM)

After market: 10.9 +0.01 (+0.09%)

10.89

-0.02 (-0.18%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)08-02 2022-08-02/bmo
Earnings (Next)10-31 2022-10-31
Inst Owners55.02%
Inst Owner Change-88.03%
Ins Owners0.38%
Ins Owner Change0%
Market Cap5.08B
Analysts81.25
Price Target12.6 (15.7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.81%
Yearly Dividend0.85
Dividend Growth(5Y)-24.82%
DP23.27%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 7.16
Fwd PE 6.72
P/S 1.03
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB N/A
EV/EBITDA 7.37
EPS(TTM)1.52
EY13.96%
EPS(NY)1.62
Fwd EY14.88%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS10.53
BVpS14.98
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.03%
ROE 14.99%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 36.91%
PM (TTM) 21.33%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.41
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC3.42%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.75%
EPS 3Y-14.33%
EPS 5Y-6.98%
EPS Q2Q%0%
EPS Next Y-0.27%
EPS Next 2Y4.29%
EPS Next 3Y7.05%
EPS Next 5Y8.37%
Revenue 1Y (TTM)33.3%
Revenue growth 3Y16.4%
Revenue growth 5Y22.92%
Sales Q2Q%-20.18%
Revenue Next Year10.11%
Revenue Next 2Y14.85%
Revenue Next 3Y-0.51%
Revenue Next 5Y-1.61%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A